BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Portincasa P, Ciaula AD, Bonfrate L, Wang DQ. Therapy of gallstone disease: What it was, what it is, what it will be. World J Gastrointest Pharmacol Ther 2012; 3(2): 7-20 [PMID: 22577615 DOI: 10.4292/wjgpt.v3.i2.7] [Cited by in CrossRef: 62] [Cited by in F6Publishing: 45] [Article Influence: 6.2] [Reference Citation Analysis]
Number Citing Articles
1 Rong ZH, Chen HY, Wang XX, Wang ZY, Xian GZ, Ma BZ, Qin CK, Zhang ZH. Effects of sphincter of Oddi motility on the formation of cholesterol gallstones. World J Gastroenterol 2016; 22(24): 5540-5547 [PMID: 27350732 DOI: 10.3748/wjg.v22.i24.5540] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
2 Tsukanov VV, Onuchina EV, Vasyutin AV, Tonkikh YL. Experience of using ursodeoxycholic acid to dissolve gallstones. Medicinskij sovet 2020. [DOI: 10.21518/2079-701x-2019-21-160-165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Chen L, Peng YT, Chen FL, Tung TH. Epidemiology, management, and economic evaluation of screening of gallstone disease among type 2 diabetics: A systematic review. World J Clin Cases 2015; 3(7): 599-606 [PMID: 26244151 DOI: 10.12998/wjcc.v3.i7.599] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
4 Wang HH, Li T, Portincasa P, Ford DA, Neuschwander-Tetri BA, Tso P, Wang DQ. New insights into the role of Lith genes in the formation of cholesterol-supersaturated bile. Liver Res 2017;1:42-53. [PMID: 34367715 DOI: 10.1016/j.livres.2017.05.005] [Cited by in Crossref: 7] [Article Influence: 1.4] [Reference Citation Analysis]
5 van Dooren I, Faouzi MEA, Foubert K, Theunis M, Pieters L, Cherrah Y, Apers S. Cholesterol lowering effect in the gall bladder of dogs by a standardized infusion of Herniaria hirsuta L. Journal of Ethnopharmacology 2015;169:69-75. [DOI: 10.1016/j.jep.2015.03.081] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
6 Wang HH, Liu M, Portincasa P, Wang DQ. Recent Advances in the Critical Role of the Sterol Efflux Transporters ABCG5/G8 in Health and Disease. Adv Exp Med Biol 2020;1276:105-36. [PMID: 32705597 DOI: 10.1007/978-981-15-6082-8_8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Shen HJ, Hsu CT, Tung TH. Economic and medical benefits of ultrasound screenings for gallstone disease. World J Gastroenterol 2015; 21(11): 3337-3343 [PMID: 25805942 DOI: 10.3748/wjg.v21.i11.3337] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
8 Yoo KS. [Management of Gallstone]. Korean J Gastroenterol 2018;71:253-9. [PMID: 29791983 DOI: 10.4166/kjg.2018.71.5.253] [Reference Citation Analysis]
9 Argiriov Y, Dani M, Tsironis C, Koizia LJ. Cholecystectomy for Complicated Gallbladder and Common Biliary Duct Stones: Current Surgical Management. Front Surg 2020;7:42. [PMID: 32793627 DOI: 10.3389/fsurg.2020.00042] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Marcason W. What medical nutrition therapy guideline is recommended post-cholecystectomy? J Acad Nutr Diet 2014;114:1136. [PMID: 24956996 DOI: 10.1016/j.jand.2014.05.009] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
11 Kube I, Tardio LB, Hofmann U, Ghallab A, Hengstler JG, Führer D, Zwanziger D. Hypothyroidism Increases Cholesterol Gallstone Prevalence in Mice by Elevated Hydrophobicity of Primary Bile Acids. Thyroid 2021;31:973-84. [PMID: 33231505 DOI: 10.1089/thy.2020.0636] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Vasconcellos M, Cozer K, Diniz VS, Baetas-da-Cruz W, Ferreira ML, Silva PC, Schanaider A. Cholecystectomy during ceftriaxone therapy. A translational study with a new rabbit model. Acta Cir Bras 2017;32:995-1005. [PMID: 29319728 DOI: 10.1590/s0102-865020170120000001] [Reference Citation Analysis]
13 Dikkers A, Tietge UJ. The neglected cousin of the hepatocyte: how gallbladder epithelial cells might contribute to cholesterol gallstone formation. Dig Dis Sci 2013;58:296-8. [PMID: 23371007 DOI: 10.1007/s10620-012-2541-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
14 DeLeon C, Wang HH, Gunn J, Wilhelm M, Cole A, Arnett S, Wang DQ, Arnatt CK. A novel GPER antagonist protects against the formation of estrogen-induced cholesterol gallstones in female mice. J Lipid Res 2020;61:767-77. [PMID: 32127396 DOI: 10.1194/jlr.RA119000592] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
15 Zhou Q, Hu H, Zhao G, Liu P, Wang Y, Zhang H. Effect and related mechanism of Yinchenhao decoction on mice with lithogenic diet-induced cholelithiasis. Exp Ther Med 2021;21:316. [PMID: 33717259 DOI: 10.3892/etm.2021.9747] [Reference Citation Analysis]
16 Altomare DF, Rotelli MT, Palasciano N. Diet After Cholecystectomy. Curr Med Chem 2019;26:3662-5. [PMID: 28521679 DOI: 10.2174/0929867324666170518100053] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
17 Bonfrate L, Wang DQ, Garruti G, Portincasa P. Obesity and the risk and prognosis of gallstone disease and pancreatitis. Best Practice & Research Clinical Gastroenterology 2014;28:623-35. [DOI: 10.1016/j.bpg.2014.07.013] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 7.0] [Reference Citation Analysis]
18 Jiang X, Yang G, Wang K, Bi W, Shang D, Zhang G. Clinical Efficacy Analysis of the Combination of the Laparoscope and Preoperative or Intraoperative Duodenoscope in the Treatment of Cholecystolithiasis with Choledocholithiasis: A Retrospective Study. J Laparoendosc Adv Surg Tech A 2019;29:1539-43. [PMID: 31647359 DOI: 10.1089/lap.2019.0541] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
19 Butorova LI, Ardatskaya MD, Osadchuk MA, Drobysheva AE, Zagrebina EA, Kadnikova NG, Kalashnikova MA, Lukianova EI, Pavlova LN, Plavnik RG, Sayutina EV, Topchiy TB, Trunova SN, Tuayeva EM, Shustova NU. [Comparative effectiveness of ursodeoxycholic acid preparations in the treatment of biliary sludge]. Ter Arkh 2020;92:60-5. [PMID: 33346463 DOI: 10.26442/00403660.2020.08.000700] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Chen G, Wu S. Role of Baicalin and Liver X Receptor Alpha in the Formation of Cholesterol Gallstones in Mice. Gastroenterol Res Pract 2020;2020:1343969. [PMID: 32382260 DOI: 10.1155/2020/1343969] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Wang DQ, Neuschwander-tetri BA, Portincasa P. The Biliary System, Second Edition. Colloquium Series on Integrated Systems Physiology: From Molecule to Function 2016;8:i-178. [DOI: 10.4199/c00147ed2v01y201611isp071] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
22 Cafasso DE, Smith RR. Symptomatic cholelithiasis and functional disorders of the biliary tract. Surg Clin North Am 2014;94:233-56. [PMID: 24679419 DOI: 10.1016/j.suc.2013.12.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Bagepally BS, Haridoss M, Sasidharan A, Jagadeesh KV, Oswal NK. Systematic review and meta-analysis of gallstone disease treatment outcomes in early cholecystectomy versus conservative management/delayed cholecystectomy. BMJ Open Gastroenterol 2021;8:e000675. [PMID: 34261757 DOI: 10.1136/bmjgast-2021-000675] [Reference Citation Analysis]
24 Stokes CS, Lammert F. Excess Body Weight and Gallstone Disease. Visc Med 2021;37:254-60. [PMID: 34540940 DOI: 10.1159/000516418] [Reference Citation Analysis]
25 Ansaloni L, Pisano M, Coccolini F, Peitzmann AB, Fingerhut A, Catena F, Agresta F, Allegri A, Bailey I, Balogh ZJ, Bendinelli C, Biffl W, Bonavina L, Borzellino G, Brunetti F, Burlew CC, Camapanelli G, Campanile FC, Ceresoli M, Chiara O, Civil I, Coimbra R, De Moya M, Di Saverio S, Fraga GP, Gupta S, Kashuk J, Kelly MD, Koka V, Jeekel H, Latifi R, Leppaniemi A, Maier RV, Marzi I, Moore F, Piazzalunga D, Sakakushev B, Sartelli M, Scalea T, Stahel PF, Taviloglu K, Tugnoli G, Uraneus S, Velmahos GC, Wani I, Weber DG, Viale P, Sugrue M, Ivatury R, Kluger Y, Gurusamy KS, Moore EE. 2016 WSES guidelines on acute calculous cholecystitis. World J Emerg Surg. 2016;11:25. [PMID: 27307785 DOI: 10.1186/s13017-016-0082-5] [Cited by in Crossref: 136] [Cited by in F6Publishing: 95] [Article Influence: 22.7] [Reference Citation Analysis]
26 Wang HH, Portincasa P, Liu M, Wang DQ. Genetic Analysis of ABCB4 Mutations and Variants Related to the Pathogenesis and Pathophysiology of Low Phospholipid-Associated Cholelithiasis. Genes (Basel) 2022;13:1047. [PMID: 35741809 DOI: 10.3390/genes13061047] [Reference Citation Analysis]
27 Micucci M, Ioan P, Aldini R, Cevenini M, Alvisi V, Ruffilli C, Chiarini A, Budriesi R. Castanea sativa Mill. extract contracts gallbladder and relaxes sphincter of Oddi in guinea pig: a natural approach to biliary tract motility disorders. J Med Food. 2014;17:795-803. [PMID: 24654975 DOI: 10.1089/jmf.2013.0090] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
28 di Gregorio MC, Cautela J, Galantini L. Physiology and Physical Chemistry of Bile Acids. Int J Mol Sci 2021;22:1780. [PMID: 33579036 DOI: 10.3390/ijms22041780] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
29 Hu FL, Chen HT, Guo FF, Yang M, Jiang X, Yu JH, Zhang FM, Xu GQ. Biliary microbiota and mucin 4 impact the calcification of cholesterol gallstones. Hepatobiliary Pancreat Dis Int 2021;20:61-6. [PMID: 33341401 DOI: 10.1016/j.hbpd.2020.12.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
30 Xiao M, Yang M, Ji X, Li D, Xie Y, Lyu Y, Zuo Z. Protective effect of Glechoma hederacea extract against gallstone formation in rodent models. BMC Complement Med Ther 2021;21:199. [PMID: 34261471 DOI: 10.1186/s12906-021-03368-1] [Reference Citation Analysis]
31 Evans M, Guthrie N, El-Khodor BF, Metzger B, Varadharaj S. A Whole-Food-Based Health Product (A-F Betafood®) Improves Gallbladder Function in Humans at Risk of Gallbladder Insufficiency: A Randomized, Placebo-Controlled Clinical Trial. Nutrients 2020;12:E540. [PMID: 32093137 DOI: 10.3390/nu12020540] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Mutha P, Shah T, Heuman D, Zfass A, Schubert ML. Choledocholithiasis Without Cholelithiasis: Should the Gallbladder Stay or Should It Go? Dig Dis Sci 2016;61:961-2. [PMID: 26738738 DOI: 10.1007/s10620-015-4003-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 Guo M, Zhang T, Dong X, Xiang JZ, Lei M, Evans T, Graumann J, Chen S. Using hESCs to Probe the Interaction of the Diabetes-Associated Genes CDKAL1 and MT1E. Cell Rep 2017;19:1512-21. [PMID: 28538172 DOI: 10.1016/j.celrep.2017.04.070] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
34 Drapkina OM, Bueverova EL. [Ursodeoxycholic acid: A therapeutic niche in an internist's practice]. Ter Arkh 2015;87:84-90. [PMID: 26087640 DOI: 10.17116/terarkh201587484-90] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
35 Castro-Torres IG, De la O-Arciniega M, Gallegos-Estudillo J, Naranjo-Rodríguez EB, Domínguez-Ortíz MÁ. Raphanus sativus L. var niger as a source of phytochemicals for the prevention of cholesterol gallstones. Phytother Res 2014;28:167-71. [PMID: 23495001 DOI: 10.1002/ptr.4964] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
36 Wang HH, Portincasa P, Liu M, Tso P, Wang DQ. Similarities and differences between biliary sludge and microlithiasis: Their clinical and pathophysiological significances. Liver Res 2018;2:186-99. [PMID: 34367716 DOI: 10.1016/j.livres.2018.10.001] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Portincasa P, Di Ciaula A, Grattagliano I. Preventing a Mass Disease: The Case of Gallstones Disease: Role and Competence for Family Physicians. Korean J Fam Med 2016;37:205-13. [PMID: 27468338 DOI: 10.4082/kjfm.2016.37.4.205] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
38 Dikman E, Soldatov A, Chirev A. The study of the possibility of drug dissolution of gallbladder calculi. SR 2020;40:363-6. [DOI: 10.1108/sr-12-2019-0301] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Di Ciaula A, Wang DQ, Portincasa P. Cholesterol cholelithiasis: part of a systemic metabolic disease, prone to primary prevention. Expert Rev Gastroenterol Hepatol 2019;13:157-71. [PMID: 30791781 DOI: 10.1080/17474124.2019.1549988] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
40 Portincasa P, Di Ciaula A, de Bari O, Garruti G, Palmieri VO, Wang DQ. Management of gallstones and its related complications. Expert Rev Gastroenterol Hepatol 2016;10:93-112. [PMID: 26560258 DOI: 10.1586/17474124.2016.1109445] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 6.3] [Reference Citation Analysis]
41 Guarino MPL, Cocca S, Altomare A, Emerenziani S, Cicala M. Ursodeoxycholic acid therapy in gallbladder disease, a story not yet completed. World J Gastroenterol 2013; 19(31): 5029-5034 [PMID: 23964136 DOI: 10.3748/wjg.v19.i31.5029] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
42 de Bari O, Wang TY, Liu M, Paik CN, Portincasa P, Wang DQ. Cholesterol cholelithiasis in pregnant women: pathogenesis, prevention and treatment. Ann Hepatol. 2014;13:728-745. [PMID: 25332259 DOI: 10.1016/s1665-2681(19)30975-5] [Cited by in Crossref: 35] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
43 Hyun JJ, Lee HS, Kim CD, Dong SH, Lee SO, Ryu JK, Lee DH, Jeong S, Kim TN, Lee J, Koh DH, Park ET, Lee IS, Yoo BM, Kim JH. Efficacy of Magnesium Trihydrate of Ursodeoxycholic Acid and Chenodeoxycholic Acid for Gallstone Dissolution: A Prospective Multicenter Trial. Gut Liver 2015;9:547-55. [PMID: 26087862 DOI: 10.5009/gnl15015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
44 Cabrera D, Arab JP, Arrese M. UDCA, NorUDCA, and TUDCA in Liver Diseases: A Review of Their Mechanisms of Action and Clinical Applications. In: Fiorucci S, Distrutti E, editors. Bile Acids and Their Receptors. Cham: Springer International Publishing; 2019. pp. 237-64. [DOI: 10.1007/164_2019_241] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
45 Castro-torres IG, De la O-arciniega M, Bravo-duarte GA, Gallegos-estudillo J, Domínguez-ortíz MÁ, Martínez-vázquez M. Intestinal and hepatic Niemann–Pick C1L1 proteins: Future therapeutic targets for cholesterol gallstones disease? European Journal of Pharmacology 2014;728:77-81. [DOI: 10.1016/j.ejphar.2014.01.067] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]